Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 5, 2000, Pages 1356-1358

  Albanèse, Jacques ^a   Léone, Marc ^a   Bruguerolle, Bernard ^b   Ayem, Marie Laure ^a   Lacarelle, Bruno ^b   Martin, Claude ^a  

^a HÔPITAL NORD   (France)

^b School of Medicine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; FEMALE; HUMAN; INFECTION; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MENINGITIS, BACTERIAL; METABOLIC CLEARANCE RATE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; VANCOMYCIN;

EID: 0034006869     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.5.1356-1358.2000     Document Type: Article

References (25)

1. Barois, A., B. Estournet, J. B. Moranne, J. Piliot, C. Chabenat, and J. Bataille. 1986. Infections ventriculaires à staphylocoque. Traitement par la vancomycine en perfusion continue. Presse Med. 15:1805-1808.
2. Brinquin, L., J. M. Rousseau, G. Boulesteix, Y. Diraison, and J. P. Bonsignour. 1993. Vancomycine en perfusion continue dans les méningites à staphylocoques post-neurochirurgicales de l'adulte. Presse Med. 22:1815-1817.
3. Desplaces, N., P. Mamoudy, F. Ducroquet, P. Larrouturou, and M. D. Kitsis. 1997. Vancomycine en perfusion continue dans le traitement des infections ostéo-articulaires chroniques à staphylocoques multirésistants. Med. Mal. Infect. 27:969-974.
4. Duffull, S. B., E. J. Begg, S. T. Chambers, and M. L. Barclay. 1994. Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model. Antimicrob. Agents Chemother. 38:2480-2482.
5. Geraci, J. E., F. R. Heilman, D. R. Nichols, W. E. Wellman, and G. T. Ross. 1956. Some laboratory and clinical experiences with a new antibiotic, vancomycin. Proc. Staff Meet. Mayo Clin. 31:564-582.
6. Goulet, O., M. Larchet, J. L. Gaillard, V. Goulet, D. Jan, Y. Revillon, S. Lortat-Jacob, P. Descamps, and C. Ricour. 1990. Catheter-related sepsis during long-term parenteral nutrition in paediatric gastroenterology patients: a study of 185 consecutive central venous catheters. Clin. Nutr. 9:73-78.
7. Gump, D. W. 1981. Vancomycin for treatment of bacterial meningitis. Rev. Infect. Dis. 3S:289-292.
8. Hawley, H. B., and D. W. Gump. 1973. Vancomycin therapy of bacterial meningitis. Am. J. Dis. Child. 126:261-264.
9. James, J. K., S. M. Palmer, D. P. Levine, and M. J. Rybak. 1996. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections. Antimicrob. Agents Chemother. 40:696-700.
10. Levine, D. P., B. S. Fromm, and B. R. Reddy. 1991. Slow response to vancomycin or vancomycin plus rifampicin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674-680.
11. Lu, D. R., and F. Mao. 1993. An interactive program for pharmacokinetic modeling. J. Pharm. Sci. 82:537-542.
12. Martin, C., M. N. Mallet, P. Saux, B. Bruguerolle, V. Herat, and F. Gouin. 1988. Tobramycin dosing in mechanically ventilated patients. Inaccuracy of a 'rule of thumb'. J. Antimicrob. Chemother. 22:505-511.
13. Regnier, B., J. J. Garaud, M. Wolff, F. Rouveix, M. Nkam, and F. Vachon. 1984. La vancomycine seule et en association aux aminosides, p. 119-131. In F. Vachon and B. Regnier (ed.), Problèmes actuels de pathologie infectieuse et de réanimation. Arnette, Paris, France.
14. Saunders, N. J. 1994. Why monitor peak vancomycin concentrations? Lancet 344:1748-1750.
15. Schaad, U. B., G. H. McCracken, Jr., and J. D. Nelson. 1980. Clinical pharmacology and efficacy of vancomycin in pediatric patients. J. Pediatr. 96:119-126.
16. Schwenzer, K. S., J. W. Chao-Huei, and J. P. Anhalt. 1983. Automated fluorescence polarization immunoassay for monitoring vancomycin. Ther. Drug Monit. 5:341-345.
17. Stratton, C. W., C. Liu, and L. S. Weeks. 1987. Activity of LY145032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies. Antimicrob. Agents Chemother. 31:1210-1215.
18. Strausbaugh, L. J., T. W. Murray, and M. A. Sande. 1980. Comparative penetration of 6 antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis. J. Antimicrob. Chemother. 6:363-371.
19. Thomas, F., P. Michel, and Y. Ravaud. 1988. Traitement d'infections à staphylocoque chez l'adulte par perfusion continue de vancomycine en monothérapie. Sem. Hop. Paris 64:215-218.
20. Van Dalen, R., and T. B. Tree. 1990. Pharmacokinetics of antibiotics in critically ill patients. Intensive Care Med. 16:5235-5238.
21. Vichyanond, P., and L. C. Olson. 1984. Staphylococcal CNS infections treated with vancomycin and rifampicin. Arch. Neurol. 41:637-639.
22. Wagner, J. G. 1975. Fundamentals of clinical pharmacokinetics, p. 217-231. Drug Intelligence Publications, Hamilton, Ontario, Canada.
23. Wysocki, M., A. Rauss, Y. Pean, F. Delatour, F. Thomas, B. Misset, C. Cheval, T. Similowski, J. F. Timsit, M. J. Laisne, H. Mentec, T. Lazard, L. Mier, D. Dreyfus s, L. Tric, P. Guerrini, C. Briard, C. Guérin, and E. Maury. 1996. Continuous infusion of vancomycin for severe methicillin-resistant staphylococcal infections. Intensive Care Med. 22:S325.
24. Wysocki, M., F. Thomas, M. Wolff, Y. Pean, Y. Ravaud, and B. Herman. 1995. Comparison of continuous with discontinuous infusion of vancomycin in severe MRSA infections. J. Antimicrob. Chemother. 35:352-354.
25. Zaske, D. E., R. J. Cipolle, and R. J. Strate. 1980. Gentamicin dosage requirements: wide interpatient variation in 242 surgery patients with normal renal function. Surgery 87:164-169.